Top 10 search results for "" in Treatments. To see all results and access other features, sign up for free.

Brovana (Arformoterol)

Overview

Brovana is a prescription drug first approved by the Food and Drug Administration (FDA) for long-term maintenance of bronchoconstriction in chronic obstructive pulmonary disease (COPD). Brovana is not… read more

Alvesco (Ciclesonide)

Overview
Alvesco is a prescription drug approved by the Food and Drug Administration (FDA) in 2008 for maintenance treatment of asthma in people 12 years of age and older. In chronic obstructive pulmonary disease… read more

Tudorza (Aclidinium bromide)

Overview
Tudorza is a prescription drug approved by the Food and Drug Administration (FDA) for maintenance treatment of bronchospasm in chronic obstructive pulmonary disease (COPD). Tudorza is not indicated for rescue… read more

Combivent Respimat (Ipratropium bromide/Albuterol)

Overview
Combivent Respimat is a prescription drug approved by the Food and Drug Administration (FDA) in 2011 to prevent bronchospasm in people with chronic obstructive pulmonary disease (COPD). Combivent Respimat is… read more

Breo Ellipta (Fluticasone/Vilanterol)

Overview

Breo Ellipta is a prescription drug approved by the Food and Drug Administration (FDA) in 2013 for daily maintenance treatment in cases of chronic obstructive pulmonary disease (COPD). Breo Ellipta helps… read more

Striverdi Respimat (Olodaterol)

Overview

Striverdi Respimat is a prescription drug approved by the Food and Drug Administration (FDA) in 2014 for daily maintenance of bronchospasms in chronic obstructive pulmonary disease (COPD). Striverdi Respimat… read more

Zemaira (Alpha1-proteinase inhibitor [human])

Overview
Zemaira is a prescription drug approved by the Food and Drug Administration (FDA) as maintenance therapy in adults who have clinically evident emphysema due to Alpha-1 antitrypsin (AAT) deficiency, a rare… read more

Anoro Ellipta (Umeclidinium/Vilanterol)

Overview
Anoro Ellipta is a prescription drug approved by the Food and Drug Administration (FDA) as long-term, once-daily maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary… read more

Prolastin-C (Alpha1-proteinase inhibitor [human])

Overview
Prolastin-C is a prescription drug approved by the Food and Drug Administration (FDA) as maintenance therapy in adults who have clinically evident emphysema due to Alpha-1 antitrypsin (AAT) deficiency, a rare… read more

Arnuity Ellipta (Fluticasone furoate)

Overview

Arnuity Ellipta is a prescription drug approved by the Food and Drug Administration (FDA) in 2014 for maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). Arnuity Ellipta is not… read more